Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
04/06/2020 - 4 minutes
Patents
Patenting Therapies in the Microbiome Field
In recent years, our understanding of the human microbiome has reached an exciting momentum. It…
17/10/2018 - 7 minutes
Doudna and Charpentier Get Second CRISPR Patent in Europe
Just a month after the European Patent Office revoked a CRISPR patent from the competitors…
01/03/2018 - 3 minutes
French Biotech Gets a CRISPR Patent for CAR-T Research
Update (16/02/2018): On top of the European patent it got last July, Cellectis now also…
16/02/2018 - 2 minutes
The European Patent Office Revokes the Broad Institute‘s CRISPR Patents
The Broad Institute has been dealt a big blow in its battle for CRISPR/Cas9 intellectual…
19/01/2018 - 3 minutes
Looking to Patent your Biotech Invention? Here’s What You Need to Know
So you've made a discovery you want to protect or an invention you want to…
29/03/2017 - 4 minutes
Europe Turns the Tables in the CRISPR Patent Battle
ERS Genomics has announced that the EPO intends to grant a patent with broad claims…
28/03/2017 - 3 minutes
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the…
15/03/2017 - 10 minutes
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The US Patent Office has ruled that the Broad Institute's CRISPR patents do not interfere…
16/02/2017 - 4 minutes
UPDATE: No Clear Winner in the CRISPR Patent Battle
Today marks an inflection point in the future of medicine: both parties fighting for the…
08/12/2016 - 3 minutes
Evotec gets hold of CRISPR in a new Partnership with Merck
Evotec teamed up with Merck to boost its drug discovery services with CRISPR, entering the…
01/12/2016 - 2 minutes
Boehringer enters the Biosimilar War against Blockbuster Humira
Boehringer Ingelheim just announced positive Phase III results for its Humira biosimilar. The company is…
27/10/2016 - 2 minutes
